Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The company is currently developing and commercialising its range of Cxbladder bladder cancer tests globally through its wholly owned central laboratories in New Zealand and the USA. As it stands Pacific Edge has four proprietary, novel, accurate, molecular diagnostic products in-market providing actionable results for the better detection and management of urothelial cancer. These products have been extensively tested and validated in international multi-center clinical studies.
Title | Date | Type |
---|---|---|
Pacific Edge 2025 Annual Shareholder Meeting – Results | Thu, Aug 07 2025 08:31 am | MEETING |
PACIFIC EDGE 2025 ANNUAL SHAREHOLDERS’ MEETING | Wed, Aug 06 2025 03:00 pm | MEETING |
Pacific Edge SPP Closes; $20.7m Of Total New Equity Pledged | Mon, Aug 04 2025 09:41 am | OFFER |
ASX 3B documents lodged | Thu, Jul 17 2025 12:09 pm | GENERAL |
Pacific Edge Opens $5.0 Million Share Purchase Plan | Thu, Jul 17 2025 08:55 am | OFFER |
Notice of Annual Shareholders' Meeting | Thu, Jul 17 2025 08:53 am | MEETING |
Pacific Edge - Cleansing Notice | Thu, Jul 17 2025 08:30 am | OFFER |
Q1 26 Cxbladder Demand Resilient Despite Coverage Loss | Mon, Jul 14 2025 09:14 am | GENERAL |
Annual Report 2025 | Mon, Jun 30 2025 10:15 am | ANNREP |
Chair to Seek Re-Election; Director Nominations | Mon, Jun 16 2025 10:55 am | GENERAL |
Date | Name | No. Held | % | Current |
---|---|---|---|---|
17/04/23 | ANZ New Zealand Investments Limited | 58,714,600 | 6.18 | 7.25 |
18/01/23 | Harbour Asset Management Limited an | 127,988,137 | 14.78 | 15.79 |
10/12/21 | Salt Funds Management Limited | 48,114,089 | 6.95 | 5.94 |
30/09/21 | Westpac Banking Corporation | 52,810,384 | 8.14 | 6.70 |
03/12/20 | AMP Capital Investors (New Zealand) | 36,125,581 | 5.16 | 4.98 |
03/12/18 | Jarden Partners Limited. | 83,613,923 | 15.60 | 17.61 |
06/06/18 | BNP Paribas Nominees (NZ) Limited a | 20,612,121 | 5.47 | 4.42 |
05/07/17 | Investment Services Group Limited | 19,015,596 | 5.94 | 4.76 |
05/07/17 | Devon Funds Management Limited | 19,015,596 | 5.94 | 4.76 |
28/06/17 | Harbour Asset Management & Jarden P | 48,540,480 | 11.11 | 12.14 |
17/02/17 | K One W One Limited | 19,786,297 | 5.39 | 4.96 |
07/11/16 | Superlife Trustee Nominees Limited, | 2,033,501 | 5.99 | 0.53 |
Date | Name | No. Held | % | Details | Other |
---|---|---|---|---|---|
21/12/22 | Peter Meintjes | 185,000 | - | - | - |
22/03/22 | Antony George Barclay | 20,000 | - | - | - |
09/12/21 | Bryan Williams | 237,427 | - | - | - |
22/10/21 | David Gregory Darling | 4,611,562 | - | - | - |
22/10/21 | Grant Edward Gibson | 27,456 | - | - | - |
20/10/21 | Sarah Park | 58,591 | - | - | - |
06/10/21 | Chris Gallaher | 602,058 | - | - | - |
16/03/21 | Anna Kate Stove | 5,000 | - | - | - |
19/12/19 | Kate Elizabeth Rankin | 1,775,890 | - | - | - |
16/08/19 | James Miller Suttie | 190,568 | - | - | - |
30/05/19 | John Duncan | 900,333 | - | - | - |
30/06/16 | Christopher John Swann | 1,171,641 | 0.37 | - | - |